Hebert A, Schrieber R, Glaab D, Eichenfield L. Phase IV Open Label Evaluation of the Adrenal Suppression Potential and Pharmacokinetic Properties of Twice Daily Halobetasol propionate Foam, 0.05% in Adolescent Subjects with Plaque Psoriasis. J of Skin [Internet]. 2020 Oct. 27 [cited 2024 Jul. 3];4(6):s77. Available from: https://jofskin.org/33014/index.php/skin/article/view/1110